Publications in collaboration with researchers from University Hospital of Lausanne (12)

2024

  1. Current Challenges and Advances on Infectious Diseases in Solid Organ Transplantation

    Transplant International

2023

  1. Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?

    Transplant International, Vol. 36

2021

  1. Infectious complications and graft outcome following treatment of acute antibodymediated rejection after kidney transplantation: A nationwide cohort study

    PLoS ONE, Vol. 16, Núm. 4 April

  2. Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 8, pp. 1379-1385

  3. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

2020

  1. COVID-19: A global transplant perspective on successfully navigating a pandemic

    American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1773-1779

2019

  1. Impact of MBL2 gene polymorphisms on the risk of infection in solid organ transplant recipients: A systematic review and meta-analysis

    American Journal of Transplantation, Vol. 19, Núm. 4, pp. 1072-1085

2018

  1. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

    Clinical Microbiology and Infection, Vol. 24, pp. S95-S107

  2. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)

    Clinical Microbiology and Infection, Vol. 24, pp. S2-S9

  3. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)

    Clinical Microbiology and Infection, Vol. 24, pp. S21-S40

2017

  1. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9